Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.56
-0.33 (-0.95%)
Feb 21, 2025, 4:00 PM EST - Market closed
HRMY Employees
Harmony Biosciences Holdings had 246 employees as of December 31, 2023. The number of employees increased by 46 or 23.00% compared to the previous year.
Employees
246
Change (1Y)
46
Growth (1Y)
23.00%
Revenue / Employee
$2,771,866
Profits / Employee
$498,476
Market Cap
1.97B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | 150 | 0 | - |
| Dec 31, 2019 | 150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
HRMY News
- 2 days ago - Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder - Benzinga
- 3 days ago - Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia - Business Wire
- 4 days ago - Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - Business Wire
- 4 weeks ago - Harmony Biosciences: Don't Sleep On This Enterprising, Profitable Biotech - Seeking Alpha
- 5 weeks ago - Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts - Business Wire
- 2 months ago - HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 2 months ago - HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT - PRNewsWire
- 3 months ago - HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - PRNewsWire